Literature DB >> 26263434

Plasma-Mediated Gut Protection After Hemorrhagic Shock is Lessened in Syndecan-1-/- Mice.

Kechen Ban1, Zhanglong Peng, Shibani Pati, Richard B Witkov, Pyong Woo Park, Rosemary A Kozar.   

Abstract

We have shown in a rodent model of hemorrhagic shock (HS) that fresh frozen plasma (FFP) reduces lung inflammation and injury that are correlated with restitution of syndecan-1. As the gut is believed to contribute to distant organ injury and inflammation after shock, the current study sought to determine if the protective effects of plasma would extend to the gut and to elucidate the contribution of syndecan-1 to this protective effect. We also examined the potential role of TNFα, and a disintegrin and metalloproteinase (ADAM)-17, both intestinal sheddases of syndecan-1. Wild-type (WT) and syndecan-1 (KO) mice were subjected to HS followed by resuscitation with lactated Ringer's (LR) or FFP and compared with shock alone and shams. Small bowel and blood were obtained after 3  h for analysis of mucosal injury and inflammation and TNFα and ADAM-17 protein expression and activity. After HS, gut injury and inflammation were significantly increased compared with shams. Resuscitation with LR decreased both injury and inflammation that were further lessened by FFP. KO mice displayed worsened gut injury and inflammation after HS compared with WT mice, and LR and FFP equivalently inhibited injury and inflammation. Both systemic and intestinal TNFα and ADAM-17 followed similar trends, with increases after HS, reduction by LR, and a further decrease by FFP in WT but not KO mice. In conclusion, FFP decreased gut injury and inflammation after hemorrhagic shock, an effect that was abrogated in syndecan-1 mice. Plasma also decreased TNFα and ADAM-17, representing a potential mechanistic link to its protection via syndecan-1.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26263434      PMCID: PMC4816460          DOI: 10.1097/SHK.0000000000000452

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  32 in total

1.  Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on enterocyte shedding of syndecan-1 and associated decreases in internalization of Listeria monocytogenes and Staphylococcus aureus.

Authors:  Michelle J Henry-Stanley; Bin Zhang; Stanley L Erlandsen; Carol L Wells
Journal:  Cytokine       Date:  2006-08-01       Impact factor: 3.861

2.  Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance.

Authors:  Christian Jung; Georg Fuernau; Phillip Muench; Steffen Desch; Ingo Eitel; Gerhard Schuler; Volker Adams; Hans R Figulla; Holger Thiele
Journal:  Shock       Date:  2015-05       Impact factor: 3.454

3.  Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia.

Authors:  Annabelle Cesaro; Abakar Abakar-Mahamat; Patrick Brest; Sandra Lassalle; Eric Selva; Jérôme Filippi; Xavier Hébuterne; Jean-Pierre Hugot; Alain Doglio; Franck Galland; Philippe Naquet; Valérie Vouret-Craviari; Baharia Mograbi; Paul M Hofman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

4.  Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.

Authors:  Anurag Purushothaman; Ligong Chen; Yang Yang; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

5.  Early cytokine production risk stratifies trauma patients for multiple organ failure.

Authors:  Kenneth M Jastrow; Ernest A Gonzalez; Mary F McGuire; James W Suliburk; Rosemary A Kozar; Sriram Iyengar; Deborah A Motschall; Bruce A McKinley; Frederick A Moore; David W Mercer
Journal:  J Am Coll Surg       Date:  2009-06-28       Impact factor: 6.113

6.  Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.

Authors:  Markus Rehm; Dirk Bruegger; Frank Christ; Peter Conzen; Manfred Thiel; Matthias Jacob; Daniel Chappell; Mechthild Stoeckelhuber; Ulrich Welsch; Bruno Reichart; Klaus Peter; Bernhard F Becker
Journal:  Circulation       Date:  2007-10-08       Impact factor: 29.690

7.  Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines.

Authors:  Kazutaka Hayashida; William C Parks; Pyong Woo Park
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

8.  Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function.

Authors:  Lars Bode; Camilla Salvestrini; Pyong Woo Park; Jin-Ping Li; Jeffrey D Esko; Yu Yamaguchi; Simon Murch; Hudson H Freeze
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion.

Authors:  Daniel Chappell; Matthias Jacob; Klaus Hofmann-Kiefer; Markus Rehm; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Cardiovasc Res       Date:  2009-03-22       Impact factor: 10.787

10.  An adequately robust early TNF-alpha response is a hallmark of survival following trauma/hemorrhage.

Authors:  Rajaie Namas; Ali Ghuma; Andres Torres; Patricio Polanco; Hernando Gomez; Derek Barclay; Lisa Gordon; Sven Zenker; Hyung Kook Kim; Linda Hermus; Ruben Zamora; Matthew R Rosengart; Gilles Clermont; Andrew Peitzman; Timothy R Billiar; Juan Ochoa; Michael R Pinsky; Juan Carlos Puyana; Yoram Vodovotz
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

View more
  14 in total

1.  Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials.

Authors:  Anthony E Pusateri; Ernest E Moore; Hunter B Moore; Tuan D Le; Francis X Guyette; Michael P Chapman; Angela Sauaia; Arsen Ghasabyan; James Chandler; Kevin McVaney; Joshua B Brown; Brian J Daley; Richard S Miller; Brian G Harbrecht; Jeffrey A Claridge; Herb A Phelan; William R Witham; A Tyler Putnam; Jason L Sperry
Journal:  JAMA Surg       Date:  2020-02-19       Impact factor: 14.766

2.  Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis.

Authors:  Hunter B Moore; Ernest E Moore; Benjamin R Huebner; Gregory R Stettler; Geoffrey R Nunns; Peter M Einersen; Christopher C Silliman; Angela Sauaia
Journal:  J Surg Res       Date:  2017-05-08       Impact factor: 2.192

3.  Loss of Syndecan-1 Abrogates the Pulmonary Protective Phenotype Induced by Plasma After Hemorrhagic Shock.

Authors:  Feng Wu; Zhanglong Peng; Pyong Woo Park; Rosemary A Kozar
Journal:  Shock       Date:  2017-09       Impact factor: 3.454

4.  Lack of species-specific difference in pulmonary function when using mouse versus human plasma in a mouse model of hemorrhagic shock.

Authors:  Zhanglong Peng; Shibani Pati; Magali J Fontaine; Kelly Hall; Anthony V Herrera; Rosemary A Kozar
Journal:  J Trauma Acute Care Surg       Date:  2016-11       Impact factor: 3.313

Review 5.  Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis?

Authors:  Hunter B Moore; Robert D Winfield; Mayuki Aibiki; Matthew D Neal
Journal:  Shock       Date:  2017-08       Impact factor: 3.454

6.  Re: ADAM-17: A potential therapeutic target to prevent organ injury after hemorrhagic shock?

Authors:  Rosemary A Kozar
Journal:  J Trauma Acute Care Surg       Date:  2017-05       Impact factor: 3.313

7.  Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial.

Authors:  Hunter B Moore; Ernest E Moore; Michael P Chapman; Kevin McVaney; Gary Bryskiewicz; Robert Blechar; Theresa Chin; Clay Cothren Burlew; Fredric Pieracci; F Bernadette West; Courtney D Fleming; Arsen Ghasabyan; James Chandler; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

8.  Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.

Authors:  Zhanglong Peng; Kechen Ban; Anthony LeBlanc; Rosemary A Kozar
Journal:  J Trauma Acute Care Surg       Date:  2016-08       Impact factor: 3.313

Review 9.  Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Shock       Date:  2016-07       Impact factor: 3.454

Review 10.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.